ResMed Inc. Form 8-K Summary
Business Context and Reporting Period
ResMed Inc. (NYSE: RMD) filed this Current Report on Form 8-K on October 24, 2024. The filing primarily serves to announce the declaration of a quarterly cash dividend and references the issuance of a press release regarding the company's results of operations for the quarter ended September 30, 2024.
Key Financial Metrics
This Form 8-K does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The filing states that the results of operations for the quarter ended September 30, 2024, are described in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes and Corporate Actions
- Dividend Declaration: The Board of Directors declared a quarterly cash dividend of US $0.53 per share.
- Dividend Schedule:
- Record Date: November 7, 2024
- Payment Date: December 12, 2024
- Ex-Dividend Date: November 6, 2024
- Currency and Instruments: Dividends will be paid in U.S. currency to NYSE common stockholders. Holders of CHESS Depositary Instruments (CDIs) on the Australian Securities Exchange will receive an equivalent amount in Australian currency based on the exchange rate on the record date, reflecting a 10:1 ratio between CDIs and NYSE shares.
- ASX Waiver: ResMed received a waiver from ASX settlement operating rules to defer processing conversions between common stock and CDI registers from November 6, 2024, through November 7, 2024.
Guidance, Outlook, and Risks
The provided text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The filing explicitly notes that the information regarding the results of operations is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for specific Q3 2024 financial results, as they are not detailed in this 8-K.
- Confirm the ex-dividend date of November 6, 2024, to ensure eligibility for the $0.53 per share dividend.
- Review the exchange rate on the record date (November 7, 2024) if holding CHESS Depositary Instruments to calculate the Australian currency equivalent.
- Monitor the ASX waiver period (Nov 6–7, 2024) if planning to convert between common stock and CDI registers.